Evidence map›Paper›PMID 30348839›Full record

ArticleMolecular and cellular biology2019

A Tumor-Promoting Phorbol Ester Causes a Large Increase in APOBEC3A Expression and a Moderate Increase in APOBEC3B Expression in a Normal Human Keratinocyte Cell Line without Increasing Genomic Uracils.

Sachini U Siriwardena, Madusha L W Perera, Vimukthi Senevirathne, Jessica Stewart, Ashok S Bhagwat

Abstract read
In one paragraph

Article in Molecular and cellular biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Clinical Implications of APOBEC3-Mediated Mutagenesis in Breast Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2023
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Detection of Genomic Uracil Patterns.International journal of molecular sciences · 2021
    Review
  11. APOBEC3A catalyzes mutation and drives carcinogenesis in vivo.The Journal of experimental medicine · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sachini U SiriwardenaDepartment of Chemistry, Wayne State University, Detroit, Michigan, USA.
Madusha L W PereraDepartment of Chemistry, Wayne State University, Detroit, Michigan, USA.
Vimukthi SenevirathneDepartment of Chemistry, Wayne State University, Detroit, Michigan, USA.
Jessica StewartDepartment of Chemistry, Wayne State University, Detroit, Michigan, USA.
Ashok S BhagwatDepartment of Chemistry, Wayne State University, Detroit, Michigan, USA axb@chem.wayne.edu.ORCID 0000-0003-1188-0579

Funding

TRANSCRIPTION--INDUCED MUTATIONSR01GM057200 · NIGMS · WAYNE STATE UNIVERSITY · PI BHAGWAT, ASHOK S · 1998 to 2014
$2.6M
Mapping and Visualizing Uracils Created by AID/APOBEC Enzymes using UdgXR21AI144708 · NIAID · WAYNE STATE UNIVERSITY · PI BHAGWAT, ASHOK S · 2019 to 2020
$398k
NIAID NIH HHS R21 AI144708NIGMS NIH HHS R01 GM057200
6 · The paper itself

Abstract

Phorbol 12-myristate 13-acetate (PMA) promotes skin cancer in rodents. The mutations found in murine tumors are similar to those found in human skin cancers, and PMA promotes proliferation of human skin cells. PMA treatment of human keratinocytes increases the synthesis of APOBEC3A, an enzyme that converts cytosines in single-stranded DNA to uracil, and mutations in a variety of human cancers are attributed to APOBEC3A or APOBEC3B expression. We tested here the possibility that induction of APOBEC3A by PMA causes genomic accumulation of uracils that may lead to such mutations. When a human keratinocyte cell line was treated with PMA, both APOBEC3A and APOBEC3B gene expression increased, anti-APOBEC3A/APOBEC3B antibody bound a protein(s) in the nucleus, and nuclear extracts displayed cytosine deamination activity. Surprisingly, there was little increase in genomic uracils in PMA-treated wild-type or uracil repair-defective cells. In contrast, cells transfected with a plasmid expressing APOBEC3A acquired more genomic uracils. Unexpectedly, PMA treatment, but not APOBEC3A plasmid transfection, caused a cessation in cell growth. Hence, a reduction in single-stranded DNA at replication forks may explain the inability of PMA-induced APOBEC3A/APOBEC3B to increase genomic uracils. These results suggest that the proinflammatory PMA is unlikely to promote extensive APOBEC3A/APOBEC3B-mediated cytosine deaminations in human keratinocytes.

Indexed as

CarcinogensCell LineCell Transformation, NeoplasticCytidine DeaminaseCytosineDNA, Single-StrandedGenomicsHumansKeratinocytesMinor Histocompatibility AntigensMutagenesisNeoplasmsPhorbol EstersProteinsUracilAPOBEC3A protein, humanAPOBEC3B protein, humanCarcinogensCytidine DeaminaseCytosineDNA, Single-StrandedMinor Histocompatibility AntigensPhorbol EstersProteinsUracilAPOBEC3Aphorbol myristate acetatepsoriasisreplication fork and DNA damageuracils in DNA

Identifiers

PMID30348839
PMCPMC6290372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.